BRCA Methylation Testing Identifies a Subset of Ovarian Carcinomas without Germline Variants That Can Benefit from PARP Inhibitor.

Int J Mol Sci · 2020 · PMC7767143 · PMID 33352687

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Even if the difference did not reach statistical significance due to the limited population, it suggests that BRCA methylation pattern preferentially characterizes sporadic EOCs.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.